Preimplantation genetic testing for aneuploidy: It's déjà vu all over again!

Medicare advantage: déjà vu all over again?

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expands the role of private health plans in Medicare through prescription drug plans and a revised Medicare+Choice (M+C), renamed Medicare Advantage, program. This paper discusses the factors responsible for the failure of M+C to develop as intended in 1997 and analyzes the challenges for MMA implementation in ligh...

A pill for HIV prevention: déjà vu all over again?

Recent FDA approval of tenofovir-emtricitabine for prevention of human immunodeficiency virus (HIV) as a form of pre-exposure prophylaxis (PrEP) has led to concern about implementation of this strategy. Fifty years ago, a very similar national and international debate occurred when the oral contraceptive pill ("the Pill" or "OCP") was approved. Contentious issues included OCP safety, cost, and ...

Standardization of endoscopy reporting: déjà vu all over again?

Déjà Vu...all over again? The importance of instrument drying.

Physiology in Medicine--Déjà vu all over again.

THIS ISSUE MARKS THE BIRTH of PIM in the journal. PIM stands for Physiology in Medicine; it is an APS Publications program that has existed for many years. Under the very capable editorship of the late Dale Benos, PIM was housed in the Annals of Internal Medicine until that partnership ended a few years ago. Encouraged by the APS Publications Committee to restart PIM within the current APS rese...